Literature DB >> 27170018

Where to Now for Standardization of Anti-Rubella Virus IgG Testing.

Wayne Dimech1.   

Abstract

The lack of standardization of rubella IgG testing continues to be a problem 20 years since the standard was introduced. The situation is complex and poorly understood. As demonstrated by an article in this issue (E. Bouthry, M. Furione, D. Huzly, A. Ogee-Nwankwo, L. Hao, A. Adebayo, J. Icenogle, A. Sarasini, M. Grazia Revello, L. Grangeot-Keros, and C. Vauloup-Fellous, J Clin Microbiol 54:1720-1725, 2016, http://dx.doi.org/10.1128/JCM.00383-16), the problem remains. The situation is far from being resolved, but at least the process for change has started.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27170018      PMCID： PMC4922087          DOI： 10.1128/JCM.00800-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  The impact of rubella immunization on the serological status of women of childbearing age: a retrospective longitudinal study in Melbourne, Australia.

Authors:  Barbara H Francis; Adrian K Thomas; Catherine A McCarty
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

2.  Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter.

Authors:  W Dimech; A Bettoli; D Eckert; B Francis; J Hamblin; T Kerr; C Ryan; I Skurrie
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Reference materials and reference measurement procedures: an overview from a national metrology institute.

Authors:  David M Bunk
Journal:  Clin Biochem Rev       Date:  2007-11

4.  Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.

Authors:  Wayne Dimech; Nilukshi Arachchi; Jingjing Cai; Terri Sahin; Kim Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

5.  Assessing Immunity to Rubella Virus: a Plea for Standardization of IgG (Immuno)assays.

Authors:  Elise Bouthry; Milena Furione; Daniela Huzly; Adaeze Ogee-Nwankwo; LiJuan Hao; Adebola Adebayo; Joseph Icenogle; Antonella Sarasini; Maria Grazia Revello; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

6.  Eliminating congenital rubella: a seroepidemiological study on women of childbearing age and MMR vaccine coverage in newborns.

Authors:  D Lo Giudice; G Cannavò; A Capua; O C Grillo; V La Fauci; A Puliafito; D Sindoni; R Squeri; S Calimeri
Journal:  J Prev Med Hyg       Date:  2009-12

7.  Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine.

Authors:  M G Cusi; G M Rossolini; C Cellesi; P E Valensin
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

8.  Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results.

Authors:  Daniela Huzly; Ingeborg Hanselmann; Dieter Neumann-Haefelin; Marcus Panning
Journal:  J Clin Virol       Date:  2015-11-19       Impact factor: 3.168

Review 9.  Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.

Authors:  Wayne Dimech; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

10.  Humoral immune response to primary rubella virus infection.

Authors:  Kim M Wilson; Carlie Di Camillo; Larissa Doughty; Elizabeth M Dax
Journal:  Clin Vaccine Immunol       Date:  2006-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.